Loading...

COLL COLLEGIUM PHARMACEUTICAL INC Management Changes 8-K Filing

CLLG

CLL

COLLEGIUM PHARMACEUTICAL INC

(COLL)

2026 8-K

Annual Meeting Results

Acquisition Completed

Financial Results Announcement

Company Acquisition

Earnings Report

2026 Revenue Guidance

Credit Agreement Details

Earnings Report

Financial Statements

Management Change

Board Expansion

2025 Financial Guidance

Merger Announcement

CEO Appointment

Merger Completion

Earnings Reports

Merger Agreement and Loan A...

FDA Exclusivity Granted

Appointment, Separation Agr...

Annual Meeting Voting Results

Share Repurchase Agreement

Management Change

Earnings Reports

Authorized Generic Agreement

Redemption of Convertible S...

Earnings Reports

Press Release and Investor ...

Share Repurchase Agreement

FDA Exclusivity Grant

Share Repurchase Agreement

Earnings Reports

Earnings Reports

Financial Results Announcement

Material Definitive Agreement

Earnings Reports

Press Release and Share Rep...

External Links:

Collegium Pharmaceutical, Inc. announced that John Fallon will retire from the Board on April 2, 2026, and Michael Donovan has been nominated for election at the 2026 Annual Meeting on April 6, 2026. This event signifies a continuation of the board's refreshment process and is not due to any disagreement with the company.

AI Assistant

COLLEGIUM PHARMACEUTICAL INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.